(Q50561525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Maria Sabrina Spano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Liana Fattore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Francesca Cadeddu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Walter Fratta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

19 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

531-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22903392%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-012-2839-1

11 February 2020

exact match

0 references

cites work

Causal association between cannabis and psychosis: examination of the evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Anxiety disorders in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The functional neuroanatomy of brain cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Clozapine: an atypical neuroleptic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Long-lasting handling affects behavioural reactivity in adult rats of both sexes prenatally exposed to diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabinoid self-administration in rats: sex differences and the influence of ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The endocannabinoid system and the treatment of mood and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Neuropathology of the cerebellum in schizophrenia--an update: 1996 and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Antipredator responses and defensive behavior: ecological and ethological approaches for the neurosciences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Localization of cannabinoid receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Mortality among patients with non-affective functional psychoses in a metropolitan area of south-eastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

PCP: from pharmacology to modelling schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Ketamine-induced oscillations in the motor circuit of the rat basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The incidence of schizotypy among cannabis and alcohol users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The endocannabinoid system and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Influence of cannabis abuse on schizophrenic psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Interactions between delta9-tetrahydrocannabinol and phencyclidine hydrochloride in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Role of the endogenous cannabinoid system in the regulation of motor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Reasons for cannabis use in psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Improvement in refractory psychosis with dronabinol: four case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabis use is associated with schizotypy and attentional disinhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Comorbid anxiety disorders and divalproex sodium use among partial hospital patients with psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Thigmotaxis as a test for anxiolytic activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Impact of substance abuse on the course and outcome of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Substance misuse at presentation to an early psychosis program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Impact of substance use on the onset and course of early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Endocannabinoid system and stress and anxiety responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Cerebellar white-matter changes in cannabis users with and without schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2839-1

Endocannabinoid system and synaptic plasticity: implications for emotional responses

21 January 2018

1 reference

12 December 2020

Species-specific behavior and acquisition of avoidance behavior in rats

1 reference

12 December 2020

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

12 December 2020

Cannabinoid control of motor function at the basal ganglia.

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats

1 reference

12 December 2020

Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotypes behavior and ataxia in rats

1 reference

12 December 2020

Animal models of schizophrenia: a critical review

1 reference

12 December 2020

An integrated view of pathophysiological models of schizophrenia

1 reference

12 December 2020

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

12 December 2020

Behavioral effects of chronic phencyclidine administration in rats

1 reference

12 December 2020

Paradoxical effects of very low dose MK-801

1 reference

12 December 2020

Substance abuse in patients with schizophrenia

1 reference

12 December 2020

Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines

1 reference

12 December 2020

SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine

1 reference

12 December 2020

Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats.

1 reference

12 December 2020

Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice

1 reference

12 December 2020

Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions

1 reference

12 December 2020

JL 13, an atypical antipsychotic: a preclinical review.

1 reference

12 December 2020

Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes

1 reference

12 December 2020

Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.

1 reference

12 December 2020

Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine

1 reference

12 December 2020

The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat

1 reference

12 December 2020

Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action.

1 reference

12 December 2020

Anxiety and the brain: not by neurochemistry alone

1 reference

12 December 2020

Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study

1 reference

12 December 2020

Glutamatergic animal models of schizophrenia

1 reference

12 December 2020

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

1 reference

12 December 2020

Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine

1 reference

12 December 2020

A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice

1 reference

12 December 2020

Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin

1 reference

12 December 2020

Phencyclidine-induced behavioral sensitization

1 reference

12 December 2020